PRDM9 and esophageal cancer: In esophageal cancer, lncRNA MAGI2-AS3 can recruit the histone methyltransferase EZH2 to the HOXB7 promoter region to initiate H3K27me3 and repress HOXB7 expression, resulting in enhanced tumor radiosensitivity (Cheng et al., 2020).